Assessment of pain/discomfort and their associated factors among cancer patients with chemotherapy in Bangladesh
More details
Hide details
Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
Health Education, Health and Recreation, Sport Science Faculty, Universitas Negeri Surabaya, Indonesia
Oncology department, Khwaja Yunus Ali Medical College and Hospital, Sirajgonj, Bangladesh
Publication date: 2023-04-27
Popul. Med. 2023;5(Supplement):A1542
Background and Objective: Cancer-related pain/discomfort might be a potential cause of persistent symptoms that have negative impacts or alter patients' quality of life (QOL). The aim of this study was to assess the pain/discomfort among cancer patients undergoing chemotherapy in Bangladesh. Methods: A hospital-based cross-sectional study was conducted on 415 cancer patients using a convenient sampling technique. Adult cancer patients' socioeconomic and self-reported EuroQol 5-Dimension 5-Level (EQ-5D-5L) data were collected between January 2022 and April 2022. Frequency and percentages were used to represent descriptive analysis, and Chi-Square test was performed to assess possible influencing factors with pain/discomfort. Results: Among our respondent participants, 258 (68%) patients were in the age groups of 30-59 years, and most of them 272 (66%) were males. The majority 113 (27%) of the subjects was lung cancer, 169 (41%) had stage IV cancer, and 175 (42%) completed 3-4 chemotherapy cycles. In total, 131 (32%), 141 (34%), 85 (20%), and 47 (11%) patients reported slight, moderate, severe, and extreme pain/discomfort, respectively. The results showed significant associations of pain/discomfort with cancer stage (p<0.001), smokeless tobacco use (p<0.001), chemo cycle number (p=0.001), and work status (p=0.001). Conclusions: The majority of patients experienced pain or discomfort, which was associated with cancer stages, smokeless tobacco use, chemotherapy cycle number, and work status, resulting in a poor quality of life. We need to take the initiative in pain/discomfort management or health education interventions to reduce cancer survivors' pain or discomfort, which might enhance cancer survivors' QoL in the future.
Journals System - logo
Scroll to top